BRPI0513237A - hidrolisados de proteìna para diminuição de pressão sanguìnea - Google Patents
hidrolisados de proteìna para diminuição de pressão sanguìneaInfo
- Publication number
- BRPI0513237A BRPI0513237A BRPI0513237-1A BRPI0513237A BRPI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A
- Authority
- BR
- Brazil
- Prior art keywords
- blood pressure
- protein hydrolysates
- lowering blood
- protein
- ipp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
HIDROLISADOS DE PROTEìNA PARA DIMINUIçãO DE PRESSãO SANGUìNEA A presente invenção descreve um processo para produzir IPP a partir de uma fonte de proteína, pelo que a proporção de IPP e VPP produzidos pela proteína é de pelo menos 5, de preferência pelo menos 10 e mais preferivelmente pelo menos 20, o qual compreende o uso de uma endoprotease prolina específica.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04077015 | 2004-07-12 | ||
EP04103593 | 2004-07-27 | ||
EP04106859 | 2004-12-22 | ||
PCT/EP2005/053336 WO2006005757A2 (en) | 2004-07-12 | 2005-07-12 | Blood pressure lowering oligopeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0513237A true BRPI0513237A (pt) | 2008-04-29 |
Family
ID=35784222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0513237-1A BRPI0513237A (pt) | 2004-07-12 | 2005-07-12 | hidrolisados de proteìna para diminuição de pressão sanguìnea |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070207944A1 (pt) |
EP (1) | EP1774014A2 (pt) |
JP (1) | JP2008505653A (pt) |
AU (1) | AU2005261652A1 (pt) |
BR (1) | BRPI0513237A (pt) |
CA (1) | CA2569926A1 (pt) |
EA (1) | EA011865B1 (pt) |
NZ (1) | NZ552140A (pt) |
WO (1) | WO2006005757A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004098309A1 (en) | 2003-05-05 | 2004-11-18 | Unilever N.V. | Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
DK1663298T3 (da) * | 2003-09-23 | 2019-10-14 | Dsm Ip Assets Bv | Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner |
JP5106117B2 (ja) * | 2004-12-22 | 2012-12-26 | ディーエスエム アイピー アセッツ ビー.ブイ. | 単一の酵素工程における血圧降下ペプチド |
ATE542896T1 (de) | 2004-12-23 | 2012-02-15 | Campina Nederland Holding Bv | Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung |
JP4732112B2 (ja) * | 2005-01-20 | 2011-07-27 | サッポロビール株式会社 | 発泡アルコール飲料の製造方法及びその方法を用いて製造された発泡アルコール飲料 |
ES2599859T3 (es) * | 2005-02-24 | 2017-02-03 | Dsm Ip Assets B.V. | Proceso enzimático para producir I-P-P a partir de caseína kappa |
ZA200709009B (en) * | 2005-04-28 | 2009-01-28 | Unilever Plc | Peptides having an ace inhibiting effect |
TW200803751A (en) | 2005-11-30 | 2008-01-16 | Campina Nederland Holding Bv | Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
RU2446210C2 (ru) * | 2006-02-02 | 2012-03-27 | ДСМ АйПи АССЕТС Б.В. | Пищевой продукт, содержащий специфичную к пролину протеазу, способ его производства и его применение для расщепления токсичных или аллергенных пептидов глютена |
KR101048663B1 (ko) * | 2006-02-14 | 2011-07-12 | 칼피스가부시키가이샤 | 동맥경화 예방제, 혈관 내막의 비후 억제제 및 혈관 내피 기능 개선제 |
CA2652388A1 (en) | 2006-05-15 | 2007-11-22 | Valio Ltd | New use of therapeutically useful peptides |
MX2009010427A (es) * | 2007-03-27 | 2009-10-20 | Calpis Co Ltd | Agente profilactico para la insuficiencia cardiaca. |
TWI414305B (zh) * | 2007-03-27 | 2013-11-11 | Calpis Co Ltd | 腎衰竭預防劑 |
JP5736533B2 (ja) * | 2007-07-19 | 2015-06-17 | 学校法人北里研究所 | 抗ストレス作用と嗜好性向上効果を備えたペプチド性ペットフード素材 |
WO2009065862A1 (en) * | 2007-11-23 | 2009-05-28 | Dsm Ip Assets B.V. | Improved bioactive peptide production |
WO2010046298A2 (en) * | 2008-10-21 | 2010-04-29 | Dsm Ip Assets B.V. | Improved peptide availability |
JP2011136932A (ja) * | 2009-12-28 | 2011-07-14 | Calpis Co Ltd | 脳機能改善用組成物および脳機能を改善する方法 |
NO20100370A1 (no) | 2010-03-08 | 2011-09-09 | Marine Bioproducts As | Peptidmateriale, fôrsammensetninger og preparater, og anvendelser derav. |
NO20100359A1 (no) | 2010-03-08 | 2011-09-09 | Marine Bioproducts As | Peptidmateriale og preparater og anvendelser derav. |
NO20100369A1 (no) | 2010-03-08 | 2011-09-09 | Marine Bioproducts As | Peptidmateriale, fôrsammensetning og preparater og anvendelser derav. |
JP5718741B2 (ja) * | 2011-06-24 | 2015-05-13 | カルピス株式会社 | 脳機能改善用ペプチドの酵素的製造方法 |
CN103204909B (zh) * | 2013-04-17 | 2014-09-03 | 苏州凯祥生物科技有限公司 | 一种抗高血压活性肽vppipp |
US9530146B2 (en) * | 2013-09-05 | 2016-12-27 | Dsm Ip Assets B.V. | Marketing the use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme |
FR3017536B1 (fr) * | 2014-02-18 | 2017-05-26 | Univ La Rochelle | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase |
US11918007B2 (en) * | 2017-12-14 | 2024-03-05 | Universidade Do Porto | Foodstuff composition comprising a derivate of olive pomace |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486461A (en) * | 1991-11-08 | 1996-01-23 | Novo Nordisk A/S | Casein hydrolyzate and method for production of such casein hydrolyzate |
JP4727770B2 (ja) * | 1997-09-26 | 2011-07-20 | カルピス株式会社 | 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びFischer比低下の少なくとも1つの軽減剤 |
FI113741B (fi) * | 1999-11-01 | 2004-06-15 | Valio Oy | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
JP4633876B2 (ja) * | 1999-11-11 | 2011-02-16 | カルピス株式会社 | トリペプチドの製造方法 |
AU2001255501A1 (en) * | 2000-04-21 | 2001-11-07 | Monsanto Technology Llc | Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
DE60222420T2 (de) * | 2001-07-18 | 2008-06-12 | Dsm Ip Assets B.V. | Verfahren zur hydrolyse von milcheiweissen |
WO2004098309A1 (en) * | 2003-05-05 | 2004-11-18 | Unilever N.V. | Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
-
2005
- 2005-07-12 EP EP05763056A patent/EP1774014A2/en not_active Withdrawn
- 2005-07-12 US US11/631,951 patent/US20070207944A1/en not_active Abandoned
- 2005-07-12 NZ NZ552140A patent/NZ552140A/en not_active IP Right Cessation
- 2005-07-12 BR BRPI0513237-1A patent/BRPI0513237A/pt not_active IP Right Cessation
- 2005-07-12 AU AU2005261652A patent/AU2005261652A1/en not_active Abandoned
- 2005-07-12 CA CA002569926A patent/CA2569926A1/en not_active Abandoned
- 2005-07-12 WO PCT/EP2005/053336 patent/WO2006005757A2/en active Application Filing
- 2005-07-12 EA EA200700215A patent/EA011865B1/ru not_active IP Right Cessation
- 2005-07-12 JP JP2007520831A patent/JP2008505653A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2006005757A3 (en) | 2007-03-15 |
EA200700215A1 (ru) | 2007-06-29 |
AU2005261652A1 (en) | 2006-01-19 |
CA2569926A1 (en) | 2006-01-19 |
JP2008505653A (ja) | 2008-02-28 |
WO2006005757A2 (en) | 2006-01-19 |
NZ552140A (en) | 2009-02-28 |
EA011865B1 (ru) | 2009-06-30 |
EP1774014A2 (en) | 2007-04-18 |
US20070207944A1 (en) | 2007-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513237A (pt) | hidrolisados de proteìna para diminuição de pressão sanguìnea | |
BRPI0519496A2 (pt) | processo para preparar um composto ou uma composiÇço, e, composiÇço | |
BRPI0517973A (pt) | método para purificar o fsh | |
AR050254A1 (es) | Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas | |
ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
TW200746925A (en) | Light device and method for the operation of a light device | |
BRPI0408881A (pt) | composição adoçante de alta intensidade e suprimento da mesma | |
BRPI0515940A (pt) | membro linear | |
BR0308211A (pt) | Cumarinas úteis como biomarcadores | |
BRPI0608273A2 (pt) | peptìdeos para diminuição da pressão sanguìnea a partir de glicomacropeptìdeo | |
BRPI0605833A (pt) | pregabalina livre de ácido isobutilglutárico e um processo para sua preparação | |
BRPI0517824A (pt) | processo para a sìntese de zeólita beta com dietilenotriamina | |
BR0305842A (pt) | Mistura curável, e, método | |
BR0311242A (pt) | Processo para preparar modafinil | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
BRPI0911907B8 (pt) | processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano | |
BRPI0600167A (pt) | processo para destilação de uma mistura de diisocianato-difenilimetanos isoméricos | |
AR048235A1 (es) | Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina | |
BRPI0606953A2 (pt) | lámpada de descarga de alta pressão e processo para produção de um dispositivo desgaseificador para utilização em uma lámpada | |
BRPI0514672A (pt) | polipeptìdeos de fusobacterium e métodos de uso | |
ATE402374T1 (de) | Reflektor für eine leuchte, mit einer verstellbaren reflektorwand und leuchte mit einem solchen reflektor | |
BRPI0509263A (pt) | processo para purificar mesotriona | |
BRPI0517669A (pt) | método para gerar uma imagem composta | |
WO2006067163A3 (en) | Blood pressure lowering oligopeptides in a single enzymatic step |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |